Clinical Analyzer Market: Overview
Clinical analyzers help in the diagnosis of various diseases such as cancer, kidney disorders, HIV, diabetes, and hepatitis; it utilizes measurement technologies including photometric and colorimetric testing, ion-selective potentiometry and latex agglutination to analyze samples such as plasma, blood serum, and urine. It is also used to analyze the concentration of metabolites, proteins, electrolytes, and drugs in serum and plasma sample.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Clinical Analyzer Market: Market Dynamics
Technological advancements--innovative devices such as StaRRsedInversa Automated ESR analyzer, growing awareness amongst people about personal health, the availability of diagnostic tests among the vast populations across the globe, rising number of point of care testing capabilities, increase in the frequency of in-vitro diagnostic tests and occurrence of various chronic diseases are anticipated to augment the demand for clinical chemistry analyzers. Moreover, rising geriatric population is another factor which is expected to increase the demand for this market as people aged over 65 are prone to various diseases thereby requiring frequent diagnosis/tests to be performed.
High cost of the equipment and costs related to it, requirement of qualified and trained professionals to operate the analyzer and obtain accurate results of the tests conducted, high capital requirement and stringent regulatory policies imposed by the various governments for medical devices are some of the factors that may hinder the growth rate during the forecast period.
Clinical Analyzer Market: Segmentation by Type
On the basis of the test type, the market can be segmented into electrolyte panels, lipid profiles, liver panels, basic metabolic panels, thyroid function panels and renal profiles. Basic Metabolic Panels is the dominating test in this segment owing to the increasing occurrence of lifestyle-induced diseases and rising importance of and awareness regarding point-of-care testing.
Clinical Analyzer Market: Segmentation by Product
By product, the market can be classified into analyzers, reagents and other products. Here, reagents account for the largest share in the market as a result of a broad number of reagents present in the market fulfilling different requirements of clinicians.
Clinical Analyzer Market: Segmentation by Sector
Based on the sector, the global clinical analyzer market is divided into mid and small, large, and ultra-large sector analyzers.
Clinical Analyzer Market: Segmentation by End-user
By end-users, the market can be segmented into hospitals, diagnostic laboratories, and academic research institutes, out of these segments, hospitals are dominating the market.
Clinical Analyzer Market: Segmentation by Regions
North America is the largest market for clinical analyzer market on account of robust healthcare infrastructure, greater affordability of the customers, increasing occurrence of infectious and non-infectious diseases and rising demand for laboratory automation in the clinical laboratories. Asia-Pacific is expected to have a lucrative growth owing to the development of healthcare infrastructure, increasing government initiatives for better health care and presence of a large patient base.
Clinical Analyzer Market: Competitors
Abbott Laboratories, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens AG, Danaher Corporation, Mindray Medical International Limited, and ELITechGroup., Beckman Coulter, Inc., Nova Biomedical Corporation, Mindray Medical International Limited, Johnson and Johnson, Horiba. Ltd. and Ortho-Clinical Diagnostics, Inc. are some of the major players in this market.
Clinical Analyzer Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets